DRUGS FROM ACADEMIA
نویسندگان
چکیده
منابع مشابه
Reclaiming academia from post-academia.
I s nanoscience the “first full embodiment of post-academic science”? Have many of the traditional core values of publicly funded university science been eroded to the point where they are now “part of a scientific mythology”? And is it “morally bankrupt” to draw a distinction between ‘pure’ and ‘applied’ science? These claims, which were all made in a recent commentary in Nature Nanotechnology...
متن کاملMessage from Academia Europaea
After EATCS was officially founded in 1972 the Bulletin issuer one was edited by Maurice Nivat in 73, issue two by Giorgio Ausiello in 76. I was elected EATCS Secretary and Bulletin editor at the 4 th ICALP (Turku, 1977) The regular appearance (three issues a year) was started by me with issue three: I am happy that some of the logo-design and structure that we introduced (particular the ideas ...
متن کاملResearch supervision styles in Iranian academia: from facilitation to exploitation!
number of postgraduate students has been growing exponentially in Iran in the last two decades. That is while the number of faculty has not increased proportionally to keep up with the fast growth. Hence, the student-faculty ratio has widened, turning thesis and dissertations into chaotic scene. Accordingly, this paper aims at uncovering how Iranian professors supervise postgraduate research pr...
متن کاملBovine Genomics From Academia to Industry
Two multistate United States Agricultural Experiment Station projects, North Central (NC)-1010 and National Research Support Project (NRSP)-8, collaborated on a joint presentation at the PAGXIII conference in San Diego, CA. The joint session consisted of presentations on current and future technologies for ruminant research. Topics ranged from genome discovery to tool applications. The current ...
متن کاملThe roles of academia, rare diseases, and repurposing in the development of the most transformative drugs.
Transformative drugs, defined as pharmaceuticals that are both innovative and have groundbreaking effects on patient care, are the "holy grail" of drug research and development. The sources of drug innovation are often debated, with pharmaceutical manufacturers arguing that high drug prices support innovative output from their sector. We studied the developmental histories of twenty-six drugs o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chemical & Engineering News Archive
سال: 2007
ISSN: 0009-2347,2157-4936
DOI: 10.1021/cen-v085n016.p042